Deep Molecular Profiling of Fragile X Mouse and Human Cells

Deep Molecular Profiling of Fragile X Mouse and Human Cells

FRAXA Research Foundation has awarded $90,000 to Dr. Joel Richter, Principal Investigator, and Dr. Sneha Shah, Postdoctoral Fellow, at the University of Massachusetts Medical School. They are using human induced pluripotent stem (iPS) cells to analyze gene expression in Fragile X syndrome.

Deep Molecular Profiling of Fragile XRead more

Correcting Fragile X Syndrome by Inhibiting the Synaptic RNA-Binding Protein CPEB1

Correcting Fragile X Syndrome by Inhibiting the Synaptic RNA-Binding Protein CPEB1

The Richter lab is the foremost research group in the world in the study of CPEB, a protein critical for regulation of protein synthesis. With $170,000 in grants from FRAXA Research Foundation over 2008-2011, Dr. Joel Richter of the University of MA Medical School explored whether inhibitions of the CPEB may be a viable approach for treatment of Fragile X.

Joel Richter, PhDRead more